Biopharming, Development of Transgenic, Plant-Based Pharmaceuticals, Business and Industry Trends Analysis

For the pharmaceuticals industry, the technology of biopharming (also referred to as “molecular farming”) may eventually lead to broad commercialization of drug therapies that are grown via agricultural methods.  For example, by inserting human genetic material into plants, scientists can manipulate them so they grow certain human proteins instead of natural plant proteins.  The growth in plants of transgenic therapies for humans may become widespread. While biopharming is in very early stages, scientists in several nations have serious interest in this field, and some funding is beginning to emerge.  In the EU, 23 nations have agreed to cooperate to develop…

A Representative List of Organizations that Have Used our Research and Products: